Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

CONTEXT: The ideal therapy for endometriosis (EM) and uterine fibroids (UFs) would suppress estrogenic drive to the endometrium and myometrium, while minimizing vasomotor symptoms and bone loss associated with current treatments. An integrated neurokinin-kisspeptin system involving substance P and n...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Endocrinol Metab
Main Authors: Pawsey, Steve, Mills, Edouard Gregory, Ballantyne, Elizabeth, Donaldson, Kirsteen, Kerr, Mary, Trower, Mike, Dhillo, Waljit Singh
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Online Only Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8277204/
https://ncbi.nlm.nih.gov/pubmed/33624806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab108
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki